Paper Details

  1. Home
  2. Paper Details

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.

Author: Angeles-HanSheila T, Barbar-SmileyFatima, BeckerMara L, CooperAshley M, CronRandy Q, CuelloCarlos A, EdelheitBarbara, FeldmanBrian M, FergusonPolly J, FlanaganElaine, GewanterHarry, Gillispie-TaylorMiriah, GuzmanJaime, HaysKimberly, HortonDaniel B, KimuraYukiko, Klein-GitelmanMarisa, LeeTzielan, LovellDaniel J, MannionMelissa L, MurphyKatherine, NigrovicPeter A, OmbrelloMichael J, OnelKaren B, PetersonRosemary, RabinovichC Egla, RestonJames T, SaadNadine, ShenoiSusan, SullivanNancy, SzymanskiAnn Marie, TesherMelissa, TrachtmanRebecca, TurgunbaevMarat, TurnerAmy S, TwiltMarinka, VeigaKeila

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, N.I.H., IntramuralFunding provided by the NIH for research projects within the NIH.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This clinical practice guideline provides recommendations for the management of juvenile idiopathic arthritis (JIA), including nonpharmacologic therapies, medication monitoring, immunizations, and imaging.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To provide recommendations for the management of juvenile idiopathic arthritis (JIA) with a focus on nonpharmacologic therapies, medication monitoring, immunizations, and imaging, irrespective of JIA phenotype. METHODS: We developed clinically relevant Patient/Population, Intervention, C...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/35233961

データ提供：米国国立医学図書館（NLM）

Guiding the Treatment of Juvenile Idiopathic Arthritis: A Comprehensive Guideline for Clinicians

Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disorder that affects children. This guideline from the American College of Rheumatology (ACR) provides recommendations for the management of JIA, focusing on nonpharmacologic therapies, medication monitoring, immunizations, and imaging. The guideline emphasizes the importance of shared decision-making between clinicians and patients/caregivers, ensuring that treatment plans are tailored to individual needs. This guideline is like a comprehensive map to navigate the vast desert of JIA management, providing guidance for clinicians and families.

A Multifaceted Approach to JIA Management: Balancing Individual Needs and Evidence-Based Practices

The guideline addresses a wide range of aspects of JIA management, including physical therapy, occupational therapy, dietary recommendations, medication monitoring, immunization schedules, and imaging protocols. It emphasizes the importance of considering the severity of both articular and nonarticular manifestations, as well as the patient's quality of life. This approach is like creating a sustainable oasis in the desert of JIA management, ensuring the long-term well-being of patients.

Navigating the Desert of JIA Management: The Importance of Shared Decision-Making

This guideline underscores the importance of shared decision-making between clinicians and patients/caregivers. It encourages a collaborative approach to treatment planning, ensuring that patients' voices are heard and their preferences are considered. This collaborative approach is like navigating the desert of JIA management together, ensuring that everyone is working towards the same goals.

Dr.Camel's Conclusion

This comprehensive guideline provides valuable recommendations for the management of juvenile idiopathic arthritis (JIA). It's like a detailed map to navigate the vast desert of JIA treatment, offering guidance for clinicians and families. This guideline emphasizes the importance of shared decision-making and individualized care, ensuring that patients receive the best possible treatment.
Date :
  1. Date Completed 2022-05-02
  2. Date Revised 2023-04-26
Further Info :

Pubmed ID

35233961

DOI: Digital Object Identifier

NIHMS1892179

Related Literature

Article Analysis
・Effective treatment of arthritis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.